Clinical Trials Directory

Trials / Completed

CompletedNCT02627690

Nephrologic Prognosis 10 Years After Diabetes Cell Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years – 77 Years
Healthy volunteers
Not accepted

Summary

Islet transplantation for type 1 diabetes results are still improving, and actually Insulin-independence with normal HbA1c is obtained in 50% of patients after 5 years, 80% of c-peptide positive patients. In addition to the need of 2 or 3 surgical or radiological interventions to inject islets, an immunosuppressive regimen is needed, which can be deleterious, particularly on kidneys. Moreover, long term beneficial effects of islet transplantation on stabilization or prevention of macro and micro vascular complications of diabetes has not been evaluated. In a preliminary work, it was observed a stabilisation or improvement of microvascular complications when compared to pre-transplant data. The aim of this study is to compare the evolution of diabetes complications, especially nephrologic, 10 years after islet transplantation and to compare it to patients with a brittle diabetes, 10 years after evaluation for islet transplantation, finally not performed. This case-control study will evaluate nephrologic parameters (creatinine, MDRD creatinine clearance, microalbuminuria, proteinuria) and other micro and macro-vascular complications of type 1 diabetes) before islet transplantation and 10 years after the transplantation or after the first evaluation in patients who finally did not underwent islet transplantation for various non nephrologic reasons

Conditions

Interventions

TypeNameDescription
OTHERislet transplantedislet transplantation
OTHERnon islet transplantedno islet transplantation (for a non nephrologic reason)

Timeline

Start date
2014-11-03
Primary completion
2021-11-29
Completion
2021-11-29
First posted
2015-12-11
Last updated
2022-04-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02627690. Inclusion in this directory is not an endorsement.